CeGaT and Amplexa (Denmark) will collaborate on diagnostic gene tests. Please see our joint press release.
https://www.cegat.de/web/wp-content/uploads/2017/11/CeGaT_Logo_Neu_horizontal_mit-claim.png00Brnjakovichttps://www.cegat.de/web/wp-content/uploads/2017/11/CeGaT_Logo_Neu_horizontal_mit-claim.pngBrnjakovic2012-11-16 09:27:092018-09-13 11:29:32Collaboration between CeGaT and Amplexa
CeGaT is thrilled that it is awarded finalist (Top 3) in the Clarity Challenge together with its partner Genomatix. Further information please visit the Note in Nature Medicine.
https://www.cegat.de/web/wp-content/uploads/2012/11/clarity_challenge.jpg290448Brnjakovichttps://www.cegat.de/web/wp-content/uploads/2017/11/CeGaT_Logo_Neu_horizontal_mit-claim.pngBrnjakovic2012-11-07 09:34:382018-09-13 11:29:55Finalist of the CLARITY Challenge
To celebrate its successful participation in Boston Children’s Hospital Clarity Challenge, CeGaT together with Genomatix offers a free sequencing and analysis of 18 exomes: Each applicant is entitled to a maximum of three free exomes. Each applicant needs to complete the attached application form and needs to send it to info[at]www.cegat.de All applications reaching us […]
With a total growth of more than 3,200% in the last three years, CeGaT was awarded the 2nd place in the Rising-Stars category of Deloittes Fast 50 competition. With this award Deloitte honours the 50 fastest growing companies in Germany.
https://www.cegat.de/web/wp-content/uploads/2012/11/deloitte_fast_50.jpg320448Brnjakovichttps://www.cegat.de/web/wp-content/uploads/2017/11/CeGaT_Logo_Neu_horizontal_mit-claim.pngBrnjakovic2012-11-06 08:57:442018-09-13 11:32:21CeGaT achieves 2nd place at Deloittes Fast 50 competition
CeGaT now offers nine new subpanels for neuromuscular diseases, Charcot-Marie-Tooth, and long QT-syndrome. For further information please visit our Neurodegenerative Diseases section.
https://www.cegat.de/web/wp-content/uploads/2017/11/CeGaT_Logo_Neu_horizontal_mit-claim.png00Brnjakovichttps://www.cegat.de/web/wp-content/uploads/2017/11/CeGaT_Logo_Neu_horizontal_mit-claim.pngBrnjakovic2012-09-27 09:42:592018-11-09 13:27:33New subpanels for NMD, CMT, and Long QT
Collaboration between CeGaT and Amplexa
/in About CeGaT /by BrnjakovicCeGaT and Amplexa (Denmark) will collaborate on diagnostic gene tests. Please see our joint press release.
Finalist of the CLARITY Challenge
/in Awards /by BrnjakovicCeGaT is thrilled that it is awarded finalist (Top 3) in the Clarity Challenge together with its partner Genomatix. Further information please visit the Note in Nature Medicine.
CeGaT starts FREE Exomes Project
/in About CeGaT /by BrnjakovicTo celebrate its successful participation in Boston Children’s Hospital Clarity Challenge, CeGaT together with Genomatix offers a free sequencing and analysis of 18 exomes: Each applicant is entitled to a maximum of three free exomes. Each applicant needs to complete the attached application form and needs to send it to info[at]www.cegat.de All applications reaching us […]
CeGaT achieves 2nd place at Deloittes Fast 50 competition
/in Awards /by BrnjakovicWith a total growth of more than 3,200% in the last three years, CeGaT was awarded the 2nd place in the Rising-Stars category of Deloittes Fast 50 competition. With this award Deloitte honours the 50 fastest growing companies in Germany.
New subpanels for NMD, CMT, and Long QT
/in Diagnostic Panels /by BrnjakovicCeGaT now offers nine new subpanels for neuromuscular diseases, Charcot-Marie-Tooth, and long QT-syndrome. For further information please visit our Neurodegenerative Diseases section.